Mutational Analysis of the Putative Anti-Mullerian Hormone (AMH) Binding Interface on its Type II Receptor, AMHR2
Mutational Analysis of the Putative Anti-Mullerian Hormone (AMH) Binding Interface on its Type II Receptor, AMHR2
复制标题
抗苗勒管激素(AMH) II型受体AMHR2结合界面的突变分析
DOI:
10.1210/endocr/bqaa066
复制
发表时间:
2020-07-01
期刊:
影响因子:
4.8
通讯作者:
Thompson, Thomas B.
中科院分区:
文献类型:
--
作者:
Hart, Kaitlin N.;Pepin, David;Thompson, Thomas B.
Anti-Mullerian hormone (AMH) or Mullerian inhibiting substance is a unique member of the TGF-beta family responsible for development and differentiation of the reproductive system. AMH signals through its own dedicated type II receptor, anti-Mullerian hormone receptor type II (AMHR2), providing an exclusive ligand-receptor pair within the broader TGF-beta family. In this study, we used previous structural information to derive a model of AMH bound to AMHR2 to guide mutagenesis studies to identify receptor residues important for AMH signaling. Nonconserved mutations were introduced in AMHR2 and characterized in an AMH-responsive cell-based luciferase assay and native PAGE. Collectively, our results identified several residues important for AMH signaling within the putative ligand binding interface of AMHR2. Our results show that AMH engages AMHR2 at a similar interface to how activin and BMP class ligands bind the type II receptor, ACVR2B; however, there are significant molecular differences at the ligand interface of these 2 receptors, where ACVR2B is mostly hydrophobic and AMHR2 is predominately charged. Overall, this study shows that although the location of ligand binding on the receptor is similar to ACVR2A, ACVR2B, and BMPR2; AMHR2 uses unique ligand-receptor interactions to impart specificity for AMH.